Furthermore, an investigation under the UK’s Early Access to Medicines Scheme reported instances of lung cancer metastasis after the prolonged utilization of APOC3 inhibitors (volanesorsen) (Jones et al., 2023). The gene discussed is APOC3; the disease is lung carcinoma.